Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TC Biopharm (Holdings) Plc (TCBP)

6.77   0.35 (5.45%) 11-25 12:58
Open: 6.61 Pre. Close: 6.42
High: 6.95 Low: 6.34
Volume: 18,430 Market Cap: 269(M)

Technical analysis

as of: 2022-11-25 2:00:46 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.28     One year: 10.84
Support: Support1: 3.12    Support2: 0.14
Resistance: Resistance1: 7.94    Resistance2: 9.28
Pivot: 1.89
Moving Average: MA(5): 5.36     MA(20): 1.46
MA(100): 0.55     MA(250): 0
MACD: MACD(12,26): 1.4     Signal(9): 0.6
Stochastic oscillator: %K(14,3): 83.9     %D(3): 76.5
RSI: RSI(14): 94.2
52-week: High: 7.94  Low: 0.14
Average Vol(K): 3-Month: 279 (K)  10-Days: 823 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TCBP ] has closed below upper band by 7.6%. Bollinger Bands are 2477.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.66 - 6.7 6.7 - 6.73
Low: 5.55 - 5.59 5.59 - 5.62
Close: 6.45 - 6.52 6.52 - 6.58

Company Description

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Headline News

Mon, 21 Nov 2022
Healthcare Stocks Moving Monday: IMGO, CDIO, NMTC, SHC, GMVD, TCBP, IVVD, CELU - InvestorsObserver

Mon, 21 Nov 2022
TC BioPharm (Holdings) (TCBP) Stock Adds 4560.00% This Week; Should You Buy? - InvestorsObserver

Mon, 21 Nov 2022
Imago, Sotera top healthcare gainers; G Medical, TC Biopharm lead losers' pack - Seeking Alpha

Mon, 21 Nov 2022
Individual investors among TC Biopharm (Holdings) Plc's (NASDAQ:TCBP) largest shareholders, saw gain in holdings value after stock jumped 11% last week - Simply Wall St

Fri, 04 Nov 2022
European ADRs Move Higher in Friday Trading - InvestorsObserver

Thu, 03 Nov 2022
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 1 (M)
Shares Float 11 (M)
% Held by Insiders 27.8 (%)
% Held by Institutions 12.4 (%)
Shares Short 3 (K)
Shares Short P.Month 4 (K)

Stock Financials

EPS -0.86
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.86
Profit Margin (%) 0
Operating Margin (%) -368.3
Return on Assets (ttm) -59.6
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 2.49
Sales Per Share 2.49
EBITDA (p.s.) -8.16
Qtrly Earnings Growth 0
Operating Cash Flow -6 (M)
Levered Free Cash Flow -4 (M)

Stock Valuations

PE Ratio -7.95
PEG Ratio 0
Price to Book value -7.97
Price to Sales 2.71
Price to Cash Flow -0.97

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.